Insider trades
Schneider Eugene, EVP of Ionis Pharmaceuticals IONS, has filed 0 purchases and 16 sales on the open market. Over the past 12 months that comes to a net sale of $3.7M. The latest trade was on 06/26.
Schneider Eugene
EVP, Chf Clinical Develop Ofcr
- Company
- Ionis Pharmaceuticals IONS
- First filing
- 23/02/07
- Trades
- 48 trades
- Buys / sales
- 0 / 16
- 12-month net buying
- −$3.7M
- Last trade
- 06/26
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 06/26 | 06/30 | 26,000 sh | $81.05 | $2,107,300 | −25.2% | |
| Open-market sale10b5-1 plan | 03/19 | 03/23 | 5,812 sh | $70.97 | $412,477.64 | −8.3% | |
| Open-market sale | 01/30 | 02/02 | 6,179 sh | $83.45 | $515,637.55 | −8.1% | |
| Open-market sale | 01/16 | 01/20 | 9,302 sh | $75.59 | $703,138.18 | −12.7% | |
| Open-market sale10b5-1 plan | 25/09/03 | 25/09/04 | 19,658 sh2 trades | $60.81avg. | $1,195,437.56 | −27.6% | |
| Open-market sale10b5-1 plan | 25/08/04 | 25/08/05 | 9,549 sh | $42.80 | $408,697.2 | −15.6% | |
| Open-market sale | 25/01/31 | 25/02/03 | 1,484 sh | $32.20 | $47,784.8 | −2.4% | |
| Open-market sale | 25/01/16 | 25/01/17 | 6,523 sh | $32.79 | $213,889.17 | −10.0% | |
| Open-market saleAmendment | 24/02/02 | 24/09/04 | 2,106 sh | $49.59 | $104,436.54 | −4.2% | |
| Open-market sale | 24/02/02 | 24/02/02 | 2,071 sh | $49.59 | $102,700.89 | −4.0% | |
| Open-market sale | 24/01/17 | 24/01/18 | 5,482 sh | $50.42 | $276,402.44 | −10.3% | |
| Open-market sale10b5-1 plan | 24/01/12 | 24/01/17 | 8,000 sh | $53.50 | $428,000 | −17.3% | |
| Open-market sale10b5-1 plan | 23/12/26 | 23/12/28 | 25,000 sh | $51.46 | $1,286,500 | −40.9% | |
| Open-market sale | 23/02/06 | 23/02/07 | 1,413 sh | $40.67 | $57,466.71 | −5.4% | |
| Open-market sale | 23/01/18 | 23/01/19 | 4,752 sh | $39.57 | $188,036.64 | −17.5% |